HCW Biologics
HCWB
HCWB
19 hedge funds and large institutions have $784K invested in HCW Biologics in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
59% less capital invested
Capital invested by funds: $1.9M → $784K (-$1.11M)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$64.6K | |
| 2 | +$8.98K | |
| 3 | +$4.45K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.38K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$830 |
Top Sellers
| 1 | -$4.18K | |
| 2 | -$2.51K | |
| 3 | -$2.17K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$247 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$152 |